Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Introduction: Around 65,000 children aged below 15 years develop type 1 diabetes each year all over the world (1). The incidence is rising, with some reports show a well recognised higher increases to children below 5 years (2). About 80% of patients below 15 years who are diagnosed with type 1 diabetes have DKA at diagnosis, DKA at presentation ranges from 12.8% to 80% (3). This study aimed to identify clinical presentation and criteria of type 1 diabetes in children below 5 years. Methods: This cohort study was conducted in the Diabetes Endocrine and Metabolism Paediatrics Unit at the Children's Hospital of Cairo University (DEMPU). Over a period of 6 months, thirty infants and toddlers (age less than 5 years) presenting with newly diagnosed diabetes, based on recent ISPAD guidelines (4), were included. Informed parents approval and consent was obtained before inclusion of the subjects to the study for the collection of clinical data and withdrawal of blood samples. Thorough history taking, clinical and laboratory evaluation at presentation were done. Patients were subdivided into 3 subgroups based on the age at presentation Group 1: < 6 months ( NDM) (4). Group 2: 6months to < 2 years Group 3: ≥2 to ≤5 years All data were tabulated and statistically analyzed using SPSS statistical software. Descriptive statistics including mean, standard deviations, minimum, maximum and range for numerical data; and frequency and percentages for non-numerical data. For subgroup analysis and comparison, student’s t- test was used to compare quantitative variables; and Chi-square test for qualitative variables. Statistical significance was considered at p value < 0.05. Results: Demographic data: The studied children were 15 (50%) males and 15 (50%) females with M/F ratio 1. Their age ranged from 2 to 77 months with a median of 24 months. Twenty-two (73.3%) children had history of diabetes in the family. Positive consanguinity was present in 17/30 (56.7%) children. Four families had 2 diabetic offspring, of whom two families (50%) had positive consanguinity (table 1). Identifiable environmental risk factors: Nineteen (63.3%) children had no identifiable risk factors while 11 (36.6%) showed environmental triggers. Stress was the most identified triggering risk factor in the form of maternal pregnancy and labour or family troubles which was found in 7 patients (23%) (table 2). Early introduction of cow's milk (before the age of 4 months) was detected in 3 children as a risk factor. The majority had no identifiable risk factor. Mode of presentation: Twelve patients presented with DKA (40%), 16 (53.3%) presented with classic symptoms in the form of polyuria, ploydipsia and weight loss and 2 were accidently discovered during routine workup for other conditions (figure 1). The duration of symptoms, for symptomatic cases, before diagnosis ranged from 2 to 60 days with median of 14 days. Glucose level at presentation ranged from (210 to 1875 mg/dl) mean 540.1±300.8 mg/dl and median 505 mg/dl (table 3). Of the 12 patients who presented with DKA; none were mild, 5/12 (41.7%) were of moderate severity and 7/12 (58.3%) were severe. The lowest PH was 6.8; lowest HCO3 was 2.2 mEq/dl. They received intravenous insulin infusion over a period ranging from 12 to 72 hrs with a median of 12 hrs at a dose of (0.05- 0.1 IU/kg/hour), then they were shifted to S.C. insulin. Nine patients (80%) were admitted to ICU < 2 days, and 4 patients (20%) >2 days. Among the patients presented with DKA, no significant correlation was found between blood glucose level and age at presentation, duration of symptoms, HCO3 or PH (p>0.05). However, there was a negative correlation between initial blood glucose level and age at presentation with marginal significance (p=0.051) (table 4, figure 2). Dividing the patients into subgroups: The 30 patients were classified into 3 groups according to age at presentation (figure 3). Group 1: included 6 (20%) infants who aged < 6 mo at the onset of diabetes, neonatal diabetes (NDM) . Group 2: included 9 (30%) children who aged 6 mo to 2 yrs at the onset of diabetes. Group 3: included 15 (50%) children who aged 2-5 yrs at the onset of diabetes. Group 1: 6 infants with neonatal diabetes: They included 6 patients. Three males and 3 females. Mean age at presentation was 2.5 months. Five infants (83.3%) had positive consanguinity. Five infants (83.3%) had history of DM in the family, 3 patients (50%) had positive family history for neonatal diabetes and one patient had a sibling with diagnosed diabetes at the age of 9 months. Positive consanguinity was present in 5 patients (83.3%). None of the siblings have had definitive molecular diagnosis. Groups 2 (infants) and 3 (toddlers): The following set table and figures illustrate a comparison between groups 2 and 3 as regards clinical and laboratory data. Frequency of DKA was higher in group 2, 5/9 (55%), than in group 3, 5/15 (33%). DKA was also more severe in group 2 than group 3. Four out of five cases presented with DKA of group 2 were severe DKA (80%), while only one case (20%) of five patients presenting with DKA of group 3 presented with severe DKA. Group 3 showed a female sex predominance, however, the difference was not statistically significant (p=0.7) (figure 4, table 6). Shorter mean duration of symptoms (polyuria and polydipsia) before presentation for group 2 (12 days ) versus 20 days for group 3 and the difference was not statistically significant (p=0.1). Blood glucose levels between both groups were comparable. For group 2, ranged between 221750 mg/d, median blood glucose level is 570 mg/dl. Group 3 blood glucose levels ranges were 350- 750 mg/dl with median of 510 mg/ dl and the difference was not statistically significant (p=0.8) Discussion: Studying the demographic data: Sex distribution: In the present study, male to female ratio was 1: 1. This is similar to general reports about incidence of type 1 diabetes being equal. As reported by Soltesz, (5), male to female ratio is 1:1 in most populations. In Egypt, Small studies in Cairo university over children attending DEMPU were done over (29 children diagnosed with diabetes before the age of 2.5 years, 96 children with type 1 diabetes, and 86 children with diabetes) reported male to female ratio of (1.4, 0.7, and 1.15 respectively) (6, 7, 8 (N.d.)). A previous, large study done over children with diabetes in Nile Delta and Northern Egypt, which reviewed data about newly diagnosed children over the period between 1 January 1994 and 31 December 2011 who were admitted to Mansoura University Children’s Hospital or were beneficiaries from Health Insurance services, showed total numbers for female and male patients were 891 (55.7%) and 709 (44.3%), respectively and the female/male ratio was 1.3 in favour of girls (9). Family history: In the present study, family history of diabetes (type 1 and/or type 2) was reported in 22 (73.3%) children. This study also detected 4 families, each of them had 2 diabetic offspring (26% of patients belong to diabetic family). These cases had their diabetes before 5 years of age. This was comparable to the results of a previous Turkish study which reported all cases diagnosed with T1DM was made in a 0-14-year age group in the course of one year time starting on 1 June 2010 and ending on 31 May 2011 in the city of Diyar bakr . Twenty-five patients (61%) of total of 41 patients had T1DM or T2DM in their family history (10). Consanguinity: In the current study, high rate of positive consanguinity was present: 17/30 (56.7%) children. In Egypt, several studies were carried out to determine the incidence of consanguineous mating in the general population. The recent reports say that consanguineous marriage is still high in Egypt (35.3%), especially among first cousins (86%) (11). Studying clinical data: Predisposing factors: In the current study the most frequently encountered predisposing factor was the familial stress in 7 children (23%), whether maternal pregnancy, giving birth and in one patient the separation from father and several familial troubles was reported. The 2nd most common identifiable risk factor was early introduction of cow's milk in 3 children (10%). Consumption of canned juices and canned meat products on daily bases was identified in 1 (3.3%) patient. Family stress is reported in several studies as a risk factor, particularly in the year preceding the diagnosis (5). N-Nitroso compounds that is used in diet such as processed meat products, was shown to be significantly associated with higher incidence of type 1 diabetes in many studies. Several clinical studies reported strong relation between early introduction of cow's milk and type 1 diabetes (12). Mode of presentation: DKA: In the present study, 40% of the patients presented with DKA. With the blood glucose level at presentation inversely proportional to their age with marginal significance (p=0.051). DKA frequency was 55.6% in children below 2 years (group 2) versus 33.3% in those between 2-5 years (group 3). Most of DKA patients <2 suffered severe form (4/5, 80%), while only (1/5, 20%) patient >5 years suffered severe DKA. Only one patient had fulminate fungal sinusitis as a complication and suffered another attack of DKA during the follow up period. In a previous study in DEMPU, DKA frequency at presentation among 96 patients with T1DM with mean age at onset 5.3 years was 41.7%. This was in the year 2009 (7(N.d.)). However, in another study in the year 2012, on 46 patients with T1DM who were below 2 years at time of diagnosis the frequency of DKA at presentation was as high as 87%. This was significantly higher (p= 0.0001) than patients over 5 years at onset (27.5%) (8 (N.d.)). According to Wolfsdorf et al. (13), wide geographic variability in the DKA rates at presentation; rates inversely correlate with the incidence of type 1 diabetes in the region. Frequencies varies from 15–70% in Europe and North America. DKA at diagnosis has a higher incidence in younger children (<2 yr of age). In one large study based on data from DanDiabKids, a Danish national diabetes register for children which provides clinical and biochemical data on patients with type 1 diabetes diagnosed in 1996– 2009, prevalence of DKA at diagnosis in children between 0-5 years was reported to be 25.3% and the highest of all age groups. The study also observed that very young children (<2 years) had an undesirably high prevalence of DKA (48.3%), comparable with register studies from Sweden, Finland and Germany (39.5–54.9%) (14). Conclusions and Recommendations: Diabetes in children below 5 years is still representing a potential life threatening condition. DKA is frequently the first presentation. Increase awareness of childhood diabetes, and the possibility of neonatal presentation in general population and among general medical practitioners. Higher index of suspicion is required to diagnose diabetes early in the disease before severe decompensation. Endocrinologist should pay special care to newly diagnosed cases below 5 years. They should be aware of the higher risks of fluctuating blood glucose. References: 1. DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabetes Medicine 2006; 23:857–866 2. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989– 2003 and predicted new cases 2005–20: a multicentre prospective registration study. The Lancet, 2009;373(9680), 2027-2033. 3. Usher-Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia, 2012; 55(11), 2878-2894. 4. Craig ME, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue KC. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatric diabetes, 2014;15: 4-17. 5. Soltesz G. Diabetes in the young: a paediatric and epidemiological perspective. Diabetologia, 2003;46(4): 447-454. 6. Afif A, (2012). The Association Between Kir6.2 Mutations And Type 1 Diabetes, (Unpublished doctoral thesis). Gohar N, Abdelghaffar S, Fayek NF, Madani H, Department of Chemical and Clinical Pathology, Faculty of Medicine, Cairo University 7. Farouk M, (2011). Genetics of type 1 diabetes milletus in Egyptian patients, (Unpublished doctoral thesis). Salah Aldin N, Kamel A, Mamdouh M, Bazaraa H. Peadiatric medicine department, Faculty of Medicine, Cairo University 8. Musa N, (2012). Risk factors and glycemic control of diabetes mellitus in infants, (Unpublished doctoral thesis). Hafez M, Mamdouh M, El Mougy F, Peadiatric medicine department, Faculty of Medicine, Cairo University 9. El-Ziny MAEM, Salem NAB, El-Hawary AK, Chalaby NM, Elsharkawy AAE. Epidemiology of Childhood Type 1 Diabetes Mellitus in Nile Delta, Northern Egypt-A Retrospective Study. Journal of clinical research in pediatric endocrinology, 2014;6(1):9. 10. Demirbilek H, Özbek MN, Baran RT. Incidence of Type 1 Diabetes Mellitus in Turkish Children from the Southeastern Region of the Country: A Regional Report. Journal of Clinical Resident Pediatric Endocrinology, 2013; 5(2), 98-103. 11. Shawky RM, El-Awady MY, Elsayed SM, Hamadan GE. Consanguineous matings among Egyptian population. Egyptian Journal of Medical Human Genetics, 2011;12(2):157-163. 12. Virtanen SM, Nevalainen J, Kronberg-Kippilä C, Ahonen S, Tapanainen H, Uusitalo L, Knip M. Food consumption and advanced β cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes: a nested case-control design. The American journal of clinical nutrition, 2012;95(2):471-478 13. Wolfsdorf JI, Allgrove J, Craig ME, Edge J, Glaser N, Jain V, Hanas R. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatric diabetes, 2014;15(S20):154-179. 14. Fredheim S, Johannesen J, Johansen A, Lyngsøe L, Rida H, Andersen MLM, Svensson J. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels. Diabetologia, 2013;56(5): 995-1003.